Southern Cross Hospital North Harbour

Details

Name :

Southern Cross Hospital North Harbour

Address  :

232 Wairau Road
Glenfield

Town  :

Auckland

State  :

Auckland

Country  :

NEW ZEALAND

Post Code:

0627

Phone  :

09 925 4400

Fax  :

09 925 4434

Web URL  :

Specialization
  • Cosmetic Surgery
  • ENT
  • General Surgeon
  • Maxillofacial Surgery
  • Obestetrician/Gynecologist
  • Orthopedics
  • Otolaryngologist
  • Paediatrics
  • Plastic Surgery

Description

Our North Harbour site is one of three Southern Cross hospitals in Auckland region included within our national network Facilities have recently been expanded with the addition of the Northern Surgical Centre and the site includes the only private surgical inpatient hospital on the citys North Shore The North Harbour site is also home to Waitemata Endoscopy a purposebuilt endoscopy suite within the surgical hospital

Established in 1991 our North Harbour hospital typically provides services to over 6000 patients annually and is widely known amongst patients and specialists in the area It is their fast growing demand for our services that drives new investments and that has delivered extensions and ongoing improvements to patient facilities within the hospital Recent enhancements include not only the addition of the Northern Surgical Centre with consulting rooms and a cafe but also a new specially designed intermediate care service increasing the scope and complexity of surgical services that can be provided within the private sector on Aucklands North Shore
Ambulances get top defibrillators

Three hitech defibrillators have been bought to equip Taranaki ambulances with another tool to combat cardiac arrests Yesterday Mayor Harry Duynhoven presented the new machines worth more than 30000 each to St John St John North Taranaki area committee chairman Doug Ashby said every year in New Zealand more than 1000 people went into cardiac ... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More